When patients unknowingly use an out-of-network physician—sometimes at facilities which they’ve previously confirmed to be within their network—providers and insurers appear to be blaming each other when patients get surprised by the bill.

A Los Angeles Times investigation alleges Purdue Pharma, the maker of OxyContin, continued supplying clinics and pharmacies it suspected of trafficking the highly addictive drug and never alerted law enforcement.

The space between anecdote and solid evidence can be wide. Two recent stories and a podcast investigate such a situation—this time looking at an experimental treatment for autism.

Here’s a roundup from healthcare news from California, Illinois, Ohio and Massachusetts.

Healthcare inequality is alive and well in America. A recent study, published by Health Affairs, has found that wealthy Americans now consume 43 percent more healthcare than the poorest 20 percent of Americans. 

Flash cards are moving into the healthcare industry with help from Involution Studios, which has developed packs of “Health Care Cards”.

The House appropriations bill covering HHS would increase the agency’s funding by $73.2 billion over fiscal year 2016, but includes policy amendments likely to stir up opposition among Democrats and cuts for CMS and programs tied to the Affordable Care Act.

The U.S. Food and Drug Administration has approved the first test for Human Papilloma Virus (HPV). The method uses cervical cells collected with SurePath Preservative Fluid.